Health Outcomes of Patients With Acute Coronary Syndromes Prescribed Ticagrelor in UK Primary Care: a Retrospective Cohort Study
Latest Information Update: 25 May 2017
Price :
$35 *
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- Sponsors AstraZeneca
- 03 Mar 2017 New trial record